Jin-song S. Bian

Suzhou Industrial Park
Suzhou, 215123, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

PUS7-Mediated Pseudouridylation of TGFBI Drives Vascular Remodeling in Pulmonary Hypertension.

PUS7-Mediated Pseudouridylation of TGFBI Drives Vascular Remodeling in Pulmonary Hypertension.

Journal: Circulation

Published: September 01, 2026

Discovery of Rhubarb Anthraquinones Physcion and Rhein as Functional Inhibitors of TRPV1 Against Lipopolysaccharide-Induced Neuroinflammation.

Discovery of Rhubarb Anthraquinones Physcion and Rhein as Functional Inhibitors of TRPV1 Against Lipopolysaccharide-Induced Neuroinflammation.

Journal: Molecules (Basel, Switzerland)

Published: April 21, 2026

Role of Hydrogen Sulfide Regulation of Programmed Cell Death: Implications for Cardiovascular Diseases.

Role of Hydrogen Sulfide Regulation of Programmed Cell Death: Implications for Cardiovascular Diseases.

Journal: Antioxidants & redox signaling

Published: October 25, 2025

IGFBP7 Contributes to Endothelial-to-Mesenchymal Transition and Serves as a Biomarker for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.

IGFBP7 Contributes to Endothelial-to-Mesenchymal Transition and Serves as a Biomarker for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.

Journal: American journal of respiratory cell and molecular biology

Published: September 08, 2025

Novel Insights Into Receptor Tyrosine Kinases in Pulmonary Arterial Hypertension.

Novel Insights Into Receptor Tyrosine Kinases in Pulmonary Arterial Hypertension.

Journal: Journal of the American Heart Association

Published: July 29, 2025

Na+/K+-ATPase Modulates Purinergic P2X3 Receptor Function to Drive Bone Cancer Pain.

Na+/K+-ATPase Modulates Purinergic P2X3 Receptor Function to Drive Bone Cancer Pain.

Journal: Research (Washington, D.C.)

Published: July 15, 2025

Identification and evaluation of a pinocembrin analog as a TRPV1 inhibitor with analgesic properties in murine pain models.

Identification and evaluation of a pinocembrin analog as a TRPV1 inhibitor with analgesic properties in murine pain models.

Journal: Frontiers in pharmacology

Published: February 28, 2025

STING Contributes to Pulmonary Hypertension by Targeting IFN and BMPR2 Signaling through Regulating of F2RL3.

STING Contributes to Pulmonary Hypertension by Targeting IFN and BMPR2 Signaling through Regulating of F2RL3.

Journal: American journal of respiratory cell and molecular biology

Published: June 12, 2024

o8G Site-Specifically Modified tRF-1-AspGTC: A Novel Therapeutic Target and Biomarker for Pulmonary Hypertension.

o8G Site-Specifically Modified tRF-1-AspGTC: A Novel Therapeutic Target and Biomarker for Pulmonary Hypertension.

Journal: Circulation research

Published: May 15, 2024

ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.

ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.

Journal: Circulation

Published: January 12, 2024

Pharmacology of Hydrogen Sulfide and Its Donors in Cardiometabolic Diseases.

Pharmacology of Hydrogen Sulfide and Its Donors in Cardiometabolic Diseases.

Journal: Pharmacological reviews

Published: December 18, 2023

ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17.

ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17.

Journal: Acta pharmaceutica Sinica. B

Published: April 07, 2023

Showing 1-12 of 76

Last Updated: 09/26/2026